Evaluation of bone marrow in breast cancer patients: prediction of clinical outcome and response to therapy

This publication has 60 references indexed in Scilit:

• Combined transcriptome and genome analysis of single micrometastatic cells
  Nature Biotechnology, 2002
• Epithelial Cells in Bone Marrow of Breast Cancer Patients at Time of Primary Surgery: Clinical Outcome During Long-Term Follow-Up
  Journal of Clinical Oncology, 2001
• Simultaneous Immunohistochemical Detection of Tumor Cells in Lymph Nodes and Bone Marrow Aspirates in Breast Cancer and Its Correlation With Other Prognostic Factors
  Journal of Clinical Oncology, 2001
• Cytokeratin-Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast Cancer
  New England Journal of Medicine, 2000
• Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study
  The Lancet, 1999
• Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells
  Proceedings of the National Academy of Sciences, 1999
• Prognostic value of bone marrow biopsy in operable breast cancer patients at the time of initial diagnosis: Results of a 20-year median follow-up
  Breast Cancer Research and Treatment, 1998
• Micrometastatic Breast Cancer Cells in Bone Marrow at Primary Surgery: Prognostic Value in Comparison With Nodal Status
  JNCI Journal of the National Cancer Institute, 1996
• Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up
  British Journal of Cancer, 1994
• Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases.
  Journal of Clinical Oncology, 1991